| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 6e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |